DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Wang W, Zhao J, Gui W. et al.
Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.
Br J Pharmacol 2018;
175 (03) 469-484
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.